OR WAIT null SECS An indirect comparison finds higher placebo-adjusted skin and itch responses with upadacitinib vs nemolizumab in atopic dermatitis. Upadacitinib (Rinvoq) treatment at 15 mg and 30 mg produces higher placebo-adjusted response rates than n... See more
OR WAIT null SECS Check out highlights from news published on Day 3 of the EADV Congress 2026, spanning psoriasis, cutaneous lupus, atopic dermatitis, and more. The third day of the 2026 European Academy of Dermatology and Venereology (EADV) Congress in V... See more
OR WAIT null SECS Check out highlights from news published on Day 2 of the EADV Congress 2026, spanning vitiligo, HS, atopic dermatitis, and more. Day 2 of the European Academy of Dermatology and Venereology (EADV) Congress 2026 in Vienna, Austria, brough... See more
OR WAIT null SECS Dupilumab improved overall CU-Q2oL scores and 22 of 23 items vs placebo at 24 weeks in omalizumab-naive CSU, per a pooled CUPID A and C analysis. New findings suggest dupilumab (Dupixent) improved disease-specific quality of life at the ... See more
25+ Patient Satisfaction Survey Questions That Get You Honest Answers Posted by Tim Smith in Business Continuity on September 29, 2026 TL;DR - The best patient satisfaction surveys focus on stages of the patient journey instead of relying on broad questio... See more
